You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 164 No. 12, June 28, 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Review Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (78)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Otolaryngology/ Head & Neck Surgery
 •Inflammatory Disease of Head & Neck
 •Salivary Gland Disorders
 •Connective Tissue Diseases
 •Musculoskeletal Syndromes (Chronic Fatigue, Gulf War)
 •Review
 •Immunologic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical Manifestations and Early Diagnosis of Sjögren Syndrome

Stuart S. Kassan, MD; Haralampos M. Moutsopoulos, MD, FRCP(Edin)

Arch Intern Med. 2004;164:1275-1284.

Sjögren syndrome (SS) is a common autoimmune disease evidenced by broad organ-specific and systemic manifestations, the most prevalent being diminished lacrimal and salivary gland function, xerostomia, keratoconjunctivitis sicca, and parotid gland enlargement. Primary SS presents alone, and secondary SS occurs in connection with autoimmune rheumatic diseases. In addition, symptoms do not always present concurrently. This diversity of symptomatic expression adds to the difficulty in initial diagnosis. Armed with the recently refined criteria for diagnosis, specialists, such as rheumatologists, primary care physicians, ophthalmologists, and dentists, who would otherwise focus only on those symptoms that encompass their areas of expertise, can get a comprehensive image of the presenting patient, leading to earlier identification and treatment of SS.


From the University of Colorado Health Sciences Center, Denver (Dr Kassan); and Department of Pathophysiology, School of Medicine, National University of Athens, Athens, Greece (Dr Moutsopoulos). Dr Kassan has a financial interest/relationship with Daiichi Pharmaceutical Corporation as a speaker.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Celiac Disease Must Be Evaluated in Patients With Sjögren Syndrome
Xavier Roblin, Frederic Helluwaert, and Bruno Bonaz
Arch Intern Med. 2004;164(21):2387.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Stress, coping strategies and social support in patients with primary Sjogren's syndrome prior to disease onset: a retrospective case-control study
Karaiskos et al.
Ann Rheum Dis 2009;68:40-46.
ABSTRACT | FULL TEXT  

Mannose-binding lectin-low genotypes are associated with milder systemic and immunological disease expression in primary Sjogren's syndrome
Ramos-Casals et al.
Rheumatology (Oxford) 2009;48:65-69.
ABSTRACT | FULL TEXT  

Oral involvement in primary Sjogren syndrome
Fox et al.
Journal of the American Dental Association 2008;139:1592-1601.
ABSTRACT | FULL TEXT  

Hyposalivation, xerostomia and the complete denture: A systematic review
Turner et al.
Journal of the American Dental Association 2008;139:146-150.
ABSTRACT | FULL TEXT  

Decreased CD4+CD25+bright T cells in peripheral blood of patients with primary Sjogren's syndrome
Liu et al.
Lupus 2008;17:34-39.
ABSTRACT  

Emerging biological therapies in primary Sjogren's syndrome
Ramos-Casals and Brito-Zeron
Rheumatology (Oxford) 2007;46:1389-1396.
ABSTRACT | FULL TEXT  

Cardiac involvement in systemic inflammatory diseases
Knockaert
Eur Heart J 2007;28:1797-1804.
ABSTRACT | FULL TEXT  

Predicting adverse outcomes in primary Sjogren's syndrome: identification of prognostic factors
Brito-Zeron et al.
Rheumatology (Oxford) 2007;46:1359-1362.
ABSTRACT | FULL TEXT  

MAPU: Max-Planck Unified database of organellar, cellular, tissue and body fluid proteomes
Zhang et al.
Nucleic Acids Res 2007;35:D771-D779.
ABSTRACT | FULL TEXT  

Infective Endocarditis Associated with Sjogren's Syndrome
Sughimoto et al.
Asian Cardiovasc. Thorac. Ann. 2006;14:e115-e117.
ABSTRACT | FULL TEXT  

Interstitial lung disease in primary sjogren syndrome.
Parambil et al.
Chest 2006;130:1489-1495.
ABSTRACT | FULL TEXT  

The role of epithelial cells in the initiation and perpetuation of autoimmune lesions: lessons from Sjogren's syndrome (autoimmune epithelitis)
Mitsias et al.
Lupus 2006;15:255-261.
ABSTRACT  

Immune-Related Conditions and Immune-Modulating Medications as Risk Factors for Non-Hodgkin's Lymphoma: A Case-Control Study
Engels et al.
Am J Epidemiol 2005;162:1153-1161.
ABSTRACT | FULL TEXT  

Primary Sjogren's syndrome: current and emergent aetiopathogenic concepts
Ramos-Casals and Font
Rheumatology (Oxford) 2005;44:1354-1367.
FULL TEXT  

Celiac Disease Must Be Evaluated in Patients With Sjogren Syndrome
Roblin et al.
Arch Intern Med 2004;164:2387-2387.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.